Ken Kobayashi, M.D.

Ken Kobayashi, M.D.

Former Chief Medical OfficeratPyxis Oncology· In proxies 2022–2024

Pay in FY2024-26% from the year before · Pyxis Oncology stock -13.3% the same year

Ken Kobayashi, M.D. was paid $650.4K in FY2024 (Dec), down 26%. Pyxis Oncology stock fell 13.3% that year.

Pay$100 in the stock at the end of FY21 → $14
Pay is from the Summary Compensation Table of each Pyxis Oncology proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Pyxis OncologyPublic company · 4 yr
    • Former Chief Medical Officer2022 – Present · 4 yrStock in role -79%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?